CardioScape: European Society of Cardiology & European Union to recommend transnational funding strategies for cardiovascular disease research

November 21, 2012

Brussels, Belgium - 22 November 2012: In the EU, cardiovascular disease (CVD) causes more than 1.8 million deaths and costs almost €196 billion every year. CVD research is essential for finding innovative and cost effective approaches to prevention, early diagnosis and treatment. But funding of CVD research is fragmented across Europe, with money coming from different sources and no coordination of topics.

The European Commission (EC) has granted €487,365 to the European Society of Cardiology (ESC) project CardioScape, which will survey the European CVD research funding landscape and examine the need for an ESC cardiovascular research foundation. Funding will be provided over 18 months through the EC's Seventh Framework Programme (FP7).

The Steering Committee is chaired by Professor Frans van de Werf (from University Hospital Leuven, Belgium) and meets for the first time today in Brussels.

"CardioScape will provide intelligence on where cardiovascular research funding is provided and whether it's transnational or national funding," said Scientific Coordinator Professor David Wood (from Imperial College London, UK). "This will allow us to identify where research funding opportunities are strong, where there are gaps and where funding could be improved. We will then make recommendations for future transnational research strategies."

The ESC will be supported by PNO Consultants Ltd, the UK operation of PNO Group. These pan-European innovation consultants have in depth of knowledge of all major grant programmes at regional, national and EU level. James Craven, Director at PNO, said: "We are proud and excited to be working with such a prestigious organisation as the ESC on this EC funded CardioScape project, the results of which will ultimately improve health outcomes for millions of European citizens, and hopefully further the worldwide efforts to diagnose and treat cardiovascular disease."

Specific objectives of CardioScape include:

• Survey research activities and funding for CVD research, both public and private, at national and European level

• Create a CVD research and funding database based on the survey results

• Summarise existing research and funding landscape for state-of-the-art CVD research

• Identify gaps, strengths, weaknesses and opportunities in European CVD research funding

• Produce and disseminate recommendations for a more coordinated approach to CVD research funding in Europe.

When it comes to defining future research strategy, CardioScape will inform the potential role of an ESC cardiovascular research foundation which could provide grants for transnational research in basic, clinical and population sciences. Currently the ESC does not directly support research apart from providing research fellowships for young investigators.

Professor Wood said: "If, through CardioScape we find there is an opportunity to contribute to the European transnational research agenda and the ESC could fill that gap, that would be a big incentive to create such a foundation."

He concluded: "CardioScape will provide the evidence we need to define where transnational cardiovascular research funding is required and prioritise topics for research in Europe which will benefit patients. This will translate into more effective strategies for treatment and prevention, and produce both health and economic benefits."
-end-
The full project title of CardioScape is: "A survey of the European cardiovascular research landscape and recommendations for future transnational research strategy".

European Society of Cardiology

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.